Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03836157 |
| Title | Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer |
| Recruitment | Withdrawn |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | University of Oklahoma |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | United States | Details |